Please use this identifier to cite or link to this item:
http://repositorio.ufla.br/jspui/handle/1/41741| metadata.artigo.dc.title: | Plasmapheresis treatment in COVID-19–related autoimmune meningoencephalitis: case series |
| metadata.artigo.dc.creator: | Dogan, Lerzan Kaya, Dilaver Sarikaya, Tugce Zengin, Rehile Dincer, Alp Akinci, Ibrahim Ozkan Afsar, Nazire |
| metadata.artigo.dc.subject: | Autoimmune Encephalitis COVID-19 Plasmapheresis |
| metadata.artigo.dc.publisher: | Elsevier |
| metadata.artigo.dc.date.issued: | Jul-2020 |
| metadata.artigo.dc.identifier.citation: | DOGAN, L. et al. Plasmapheresis treatment in COVID-19–related autoimmune meningoencephalitis: case series. Brain, Behavior, and Immunity, [S.l.], v. 87, p. 155-158, July 2020. |
| metadata.artigo.dc.description.abstract: | Severe SARS-CoV-2 (COVID-19) infection has the potential for a high mortality rate. In this paper, we report the results of plasmapheresis treatment in a series of severely ill patients with COVID-19–related autoimmune meningoencephalitis in the Intensive Care Unit (ICU). |
| metadata.artigo.dc.identifier.uri: | https://www.sciencedirect.com/science/article/pii/S0889159120308035 http://repositorio.ufla.br/jspui/handle/1/41741 |
| metadata.artigo.dc.language: | en_US |
| Appears in Collections: | FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19) |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.